BioMark Diagnostics Inc. BioMark Diagnostics Inc.

BioMark Diagnostics Inc.

BUX

Rank in Stocks #24403
BioMark Diagnostics Inc. is an oncology specialist, developing advanced... BioMark Diagnostics Inc. is an oncology specialist, developing advanced diagnostic tools for cancer to enable early detection, continuous patient monitoring, and the assessment of initial treatment efficacy. The firm holds a research partnership with the Icahn School of Medicine, collaborating on clinical trials specifically addressing the early identification of lung cancer. Founded in 2014, its corporate headquarters are situated in Richmond, Canada. BioMark Diagnostics Inc. operates as a subsidiary of Biomark Technologies Inc.
Share Price
$0.29374943
Last synced: 2026-11-17
Market Cap
$31.24M
Change (1 day)
-0.20%
Change (1 year)
16.70%
Country

Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this

Category

Healthcare
EPS for BioMark Diagnostics Inc. (BUX)
EPS as of June 2026 TTM: $-0.01
According to BioMark Diagnostics Inc.'s latest financial reports, its current EPS (TTM) is $-0.01. At the end of 2025 the company had an EPS of $-0.02, a decrease compared to its 2024 EPS of $-0.01.
EPS history for BioMark Diagnostics Inc. from 2014 to 2026
EPS at the end of each year
Year EPS Change
2026 (TTM) $-0.01 -52.50%
2025 $-0.02 27.64%
2024 $-0.01 -25.45%
2023 $-0.02 2.48%
2022 $-0.02 35.29%
2021 $-0.01 -1.65%
2020 $-0.01 95.16%
2019 $-0.01 -33.33%
2018 $-0.01 -6.06%
2017 $-0.01 -54.38%
2016 $-0.02 -75.00%
2015 $-0.09 159.88%
2014 $-0.03 0.00%
EPS for similar companies or competitors
Company EPS EPS Difference Country
$18.99 -199,994.74%
US
$6.12 -64,521.05%
US
$1.38 -14,584.21%
CN
$14.91 -157,047.37%
US
$5.09 -53,678.95%
US

Questions about BioMark Diagnostics Inc.'s earnings per share (EPS)

What is BioMark Diagnostics Inc.'s earnings per share (EPS)?

BioMark Diagnostics Inc.'s earnings per share (EPS) over the last twelve months is $-0.01, as of Jun 2026.

What was BioMark Diagnostics Inc.'s earnings per share (EPS) in 2025?

In 2025, BioMark Diagnostics Inc.'s earnings per share (EPS) was $-0.02, compared with $-0.01 in 2024.

How has BioMark Diagnostics Inc.'s earnings per share (EPS) changed since 2020?

From 2020 to 2025, BioMark Diagnostics Inc.'s earnings per share (EPS) was highest in 2024 ($-0.01) and lowest in 2025 ($-0.02).

How does BioMark Diagnostics Inc.'s earnings per share (EPS) compare with similar companies?

BioMark Diagnostics Inc.'s earnings per share (EPS) ($-0.01) is lower than that of all 5 similar companies listed above. The highest among them is Thermo Fisher Scientific Inc., with $18.99.